386 related articles for article (PubMed ID: 33664731)
1. Purinergic Signaling in Controlling Macrophage and T Cell Functions During Atherosclerosis Development.
Ferrari D; la Sala A; Milani D; Celeghini C; Casciano F
Front Immunol; 2020; 11():617804. PubMed ID: 33664731
[TBL] [Abstract][Full Text] [Related]
2. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
Dwyer KM; Kishore BK; Robson SC
Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760
[TBL] [Abstract][Full Text] [Related]
3. Purinergic signaling in kidney disease.
Menzies RI; Tam FW; Unwin RJ; Bailey MA
Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
[TBL] [Abstract][Full Text] [Related]
4. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
[TBL] [Abstract][Full Text] [Related]
5. Control of Gut Inflammation by Modulation of Purinergic Signaling.
Vuerich M; Mukherjee S; Robson SC; Longhi MS
Front Immunol; 2020; 11():1882. PubMed ID: 33072065
[TBL] [Abstract][Full Text] [Related]
6. Alteration of purinergic signaling in diabetes: Focus on vascular function.
Zhou R; Dang X; Sprague RS; Mustafa SJ; Zhou Z
J Mol Cell Cardiol; 2020 Mar; 140():1-9. PubMed ID: 32057736
[TBL] [Abstract][Full Text] [Related]
7. Purinergic signaling in atherosclerosis.
Ferrari D; Vitiello L; Idzko M; la Sala A
Trends Mol Med; 2015 Mar; 21(3):184-92. PubMed ID: 25637413
[TBL] [Abstract][Full Text] [Related]
8. Impact of ectoenzymes on p2 and p1 receptor signaling.
Kukulski F; Lévesque SA; Sévigny J
Adv Pharmacol; 2011; 61():263-99. PubMed ID: 21586362
[TBL] [Abstract][Full Text] [Related]
9. Diabetes and hypertension: Pivotal involvement of purinergic signaling.
Reichert KP; Castro MFV; Assmann CE; Bottari NB; Miron VV; Cardoso A; Stefanello N; Morsch VMM; Schetinger MRC
Biomed Pharmacother; 2021 May; 137():111273. PubMed ID: 33524787
[TBL] [Abstract][Full Text] [Related]
10. Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines.
Morrone FB; Jacques-Silva MC; Horn AP; Bernardi A; Schwartsmann G; Rodnight R; Lenz G
J Neurooncol; 2003 Sep; 64(3):211-8. PubMed ID: 14558596
[TBL] [Abstract][Full Text] [Related]
11. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
12. Purinergic signaling during intestinal inflammation.
Longhi MS; Moss A; Jiang ZG; Robson SC
J Mol Med (Berl); 2017 Sep; 95(9):915-925. PubMed ID: 28547076
[TBL] [Abstract][Full Text] [Related]
13. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
Yu Y; Zhang C
Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
[TBL] [Abstract][Full Text] [Related]
14. Purinergic regulation of epithelial transport.
Bucheimer RE; Linden J
J Physiol; 2004 Mar; 555(Pt 2):311-21. PubMed ID: 14694149
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide suppresses T cells by generating extracellular ATP that impairs their mitochondrial function via P2Y11 receptors.
Sueyoshi K; Ledderose C; Shen Y; Lee AH; Shapiro NI; Junger WG
J Biol Chem; 2019 Apr; 294(16):6283-6293. PubMed ID: 30787105
[TBL] [Abstract][Full Text] [Related]
16. Purinergic contribution to amyotrophic lateral sclerosis.
Volonté C; Apolloni S; Parisi C; Amadio S
Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
[TBL] [Abstract][Full Text] [Related]
17. P2 receptors: new potential players in atherosclerosis.
Di Virgilio F; Solini A
Br J Pharmacol; 2002 Feb; 135(4):831-42. PubMed ID: 11861311
[TBL] [Abstract][Full Text] [Related]
18. Purinergic mechanisms in neuroinflammation: An update from molecules to behavior.
Beamer E; Gölöncsér F; Horváth G; Bekő K; Otrokocsi L; Koványi B; Sperlágh B
Neuropharmacology; 2016 May; 104():94-104. PubMed ID: 26384652
[TBL] [Abstract][Full Text] [Related]
19. Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment.
Chiarella AM; Ryu YK; Manji GA; Rustgi AK
Trends Cancer; 2021 Aug; 7(8):731-750. PubMed ID: 34074623
[TBL] [Abstract][Full Text] [Related]
20. Purinergic signaling during macrophage differentiation results in M2 alternative activated macrophages.
Barberà-Cremades M; Baroja-Mazo A; Pelegrín P
J Leukoc Biol; 2016 Feb; 99(2):289-99. PubMed ID: 26382298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
